Beta-blockers and Short-Term Cardiovascular Outcomes In Patients Hospitalized For Acute Coronary Syndrome and a Left Ventricular Ejection Fraction ≥40% | Scientific Reports
Heart failure is no contraindication to β-blocker therapy
Beta blockers: A central role in cardiac disorders
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect
Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? | CFR Journal
Role of Beta-blockers in Cardiovascular Disease in 2019 | Revista Española de Cardiología
Role of Beta-blockers in Cardiovascular Disease in 2019 | Revista Española de Cardiología
Frontiers | Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling | Pharmacology
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action - Journal of the American Academy of Dermatology
Mechanism of Action of Beta-Blocking Agents in Heart Failure - American Journal of Cardiology
The Mechanism of action of calcium channel blockers. Ca, calcium; SMC,... | Download Scientific Diagram
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate - The American Journal of Medicine
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis | The BMJ
Beta blockers: A central role in cardiac disorders | Cardiac disorder, Medical school studying, Pharmacology nursing
Which Beta-Blocker is Most Effective in Heart Failure? | SpringerLink
Beta Blocker Therapy for Chronic Heart Failure - American Family Physician
How Long Should We Continue Beta-Blockers After MI? - American College of Cardiology